* AVITA Medical Inc RCEL.OQ reported a quarterly adjusted
loss
of 37 cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 25 cents per share.
* Revenue rose 39.9% to $10.55 million from a year ago;
analysts
expected $10.33 million.
* AVITA Medical Inc's reported EPS for the quarter was a
loss
of 37 cents.
* The mean earnings estimate of analysts had risen by
about 13.7%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* AVITA Medical Inc shares had risen by 14.7% this
quarter and
gained 142.9% so far this year.
* The company reported a quarterly loss of $9.22 million.
* Wall Street's median 12-month price target for AVITA
Medical Inc
is $18.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
12 at 03:43 a.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.25 -0.37 Missed
Dec. 31 2022 -0.29 -0.22 Beat
Sep. 30 2022 -0.34 -0.22 Beat
Jun. 30 2022 -0.39 -0.25 Beat